Type I interferon (IFN-I) accumulation down-regulates the MEF2C in microglia, leading to excess microglia responses under pro-inflammatory environments of AD or aging brains, and aggravates cognitive impairment and disease pathology [20]. The gene discussed is MEF2C; the disease is Alzheimer disease.